The latest price target for Amrize (NYSE:AMRZ) was reported by Stephens & Co. on August 12, 2026. The analyst firm set a price target for $54.00 expecting AMRZ to rise to within 12 months (a possible 18.21% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for Amrize (NYSE:AMRZ) was provided by Stephens & Co., and Amrize maintained their overweight rating.

There is no last upgrade for Amrize

The last downgrade for Amrize Ltd happened on August 10, 2026 when RBC Capital changed their price target from $60 to $48 for Amrize Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amrize, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amrize was filed on August 12, 2026 so you should expect the next rating to be made available sometime around August 12, 2027.

While ratings are subjective and will change, the latest Amrize (AMRZ) rating was a maintained with a price target of $65.00 to $54.00. The current price Amrize (AMRZ) is trading at is $45.68, which is out of the analyst’s predicted range.